Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
BEARISH SIGNAL DETECTED
██.█% Sign up free to reveal

Guided Therapeutics Inc (GTHP) AI Forecast

Our AI detected a significant signal for Guided Therapeutics Inc. Create a free account to see the exact price target.

✓ Free account • ✓ 30-day free trial

$GTHP Bearish Signal Full forecast available
Sign Up Free

Guided Therapeutics Inc (GTHP) Stock Forecast 2025

Guided Therapeutics Inc (GTHP) AI Stock Price Forecast & Investment Analysis

Guided Therapeutics Inc Stock Price Chart and Technical Analysis

Loading chart...

Guided Therapeutics Inc (GTHP) - Comprehensive Stock Analysis & Investment Research

Deep dive into Guided Therapeutics Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on March 14, 2026, 12:10 a.m. (UTC)

Guided Therapeutics Inc Investment Summary

When evaluating whether Guided Therapeutics Inc (GTHP) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Guided Therapeutics Inc (GTHP) operates within the Industrial Applications and Services sector, specifically in the Electromedical & Electrotherapeutic Apparatus industry. . With a market capitalization of $24 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Guided Therapeutics Inc's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Guided Therapeutics Inc along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Guided Therapeutics Inc is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Guided Therapeutics Inc

Sign Up Free
Corporate Identity

Guided Therapeutics Inc (Stock Symbol: GTHP) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Electromedical & Electrotherapeutic Apparatus industry. The company's shares are publicly traded on the OTC exchange.

Leadership & Workforce

Detailed information about Guided Therapeutics Inc's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Guided Therapeutics Inc...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Guided Therapeutics Inc...

Unlock Full Company Profile

Get complete details about Guided Therapeutics Inc

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Guided Therapeutics Inc...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Guided Therapeutics Inc...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Guided Therapeutics Inc...

Unlock Financial Analysis

Get complete financial metrics for Guided Therapeutics Inc

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Guided Therapeutics Inc's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Guided Therapeutics Inc strategically competes in the highly dynamic Electromedical & Electrotherapeutic Apparatus marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Guided Therapeutics Inc competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Financial Strength & Leverage

Guided Therapeutics Inc (GTHP) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Guided Therapeutics Inc stock analysis.

Deep dive into Guided Therapeutics Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Guided Therapeutics Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Guided Therapeutics Inc:

P/B Ratio 21.40x
Market Cap $24M
EPS $-0.05
Book Value/Share $0.01
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Guided Therapeutics Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Guided Therapeutics Inc:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess Guided Therapeutics Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Guided Therapeutics Inc:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Guided Therapeutics Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Guided Therapeutics Inc:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Guided Therapeutics Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Guided Therapeutics Inc:

Understanding Financial Statement Data

What these metrics mean: Key figures from Guided Therapeutics Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Guided Therapeutics Inc:

Income Statement
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 84M

Latest Guided Therapeutics Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Guided Therapeutics Inc (GTHP) stock price and investment outlook.

More news available

Sign up free to read all 7 news articles and stay updated on market developments.

Sign Up Free to Read More

Guided Therapeutics Inc Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Guided Therapeutics Inc against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Adm Tronics Unlimited, Inc. ADMT ██% $6M 153.9x 8.0x
Axogen, Inc. AXGN ██% $1.50B -41.7x 11.6x
Biolife Solutions Inc BLFS ██% $875M -14.7x 2.4x
Ceribell, Inc. CBLL ██% $688M x 4.4x
Conmed Corp CNMD ██% $1.14B 24.2x 1.1x
Capsovision, Inc CV ██% $251M x 12.3x
Electrocore, Inc. ECOR ██% $48M -7.3x 43.4x
Edap Tms Sa EDAP ██% $164M x 4.0x
Electromed, Inc. ELMD ██% $193M 21.4x 4.2x
Endonovo Therapeutics, Inc. ENDV ██% $180K 0.0x x
Escalon Medical Corp ESMC ██% $2M 14.3x 1.1x
Fonar Corp FONR ██% $127M 39.1x 0.7x
Guided Therapeutics Inc GTHP ██% $24M x 21.4x
Solana Co HSDT ██% $110M 0.0x 18.3x
Hyperfine, Inc. HYPR ██% $114M -1.8x 4.2x
Inmode Ltd. INMD ██% $808M x 1.2x
Iridex Corp IRIX ██% $23M -2.8x 4.8x
Ir-Med, Inc. IRME ██% $110K x 54.9x
Integer Holdings Corp ITGR ██% $2.86B 27.8x 1.6x
Livanova Plc LIVN ██% $3.38B -662.0x 2.8x
Masimo Corp MASI ██% $9.14B 128.1x 12.7x
Medtronic Plc MDT ██% $115.36B 25.0x 2.4x
Endra Life Sciences Inc. NDRA ██% $4M -0.8x 22.9x
Non Invasive Monitoring Systems Inc /Fl/ NIMU ██% $360K x x
Neuraxis, Inc NRXS ██% $64M -0.9x 28.0x
Nuwellis, Inc. NUWE ██% $1M -0.1x 0.4x
Nexalin Technology, Inc. NXL ██% $8M -4.7x 1.7x
Outset Medical, Inc. OM ██% $61M -0.4x 0.5x
Precision Optics Corporation, Inc. POCI ██% $35M -11.5x 3.7x
Semler Scientific, Inc. SMLR ██% $308M 6.4x 0.7x
Star Operating Companies, Inc. STRR ██% $33M -1.6x 0.5x
Star Operating Companies, Inc. STRRP ██% $32M -5.5x 0.5x
Stereotaxis, Inc. STXS ██% $172M -8.4x 12.8x
Tivic Health Systems, Inc. TIVC ██% $2M 0.0x 0.4x
Transmedics Group, Inc. TMDX ██% $4.20B 22.1x 8.9x
Vivani Medical, Inc. VANI ██% $90M -2.7x 68.6x
Vaso Corp VASO ██% $30M 11.6x 1.1x
Yubo International Biotech Ltd YBGJ ██% $3M x x
Zynex Inc ZYXI ██% $3M 41.4x 13.7x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Guided Therapeutics Inc Stock Forecast

How accurate are Guided Therapeutics Inc stock predictions?

Our AI model shows a -31% Spearman correlation coefficient for GTHP predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Guided Therapeutics Inc stock price forecasts?

Our analysis considers Guided Therapeutics Inc's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Guided Therapeutics Inc a good investment in 2025?

Based on our AI analysis, Guided Therapeutics Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Guided Therapeutics Inc forecasts updated?

Guided Therapeutics Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

My Portfolio

Investment Dashboard

Loading your portfolio...